You have 9 free searches left this month | for more free features.

Tamoxifen

Showing 26 - 50 of 865

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Breast Cancer Trial in Toulouse (Treatment requiring adjuvant Hormonal Therapy (HT) with tamoxifen.)

Recruiting
  • Breast Cancer
  • Treatment requiring adjuvant Hormonal Therapy (HT) with tamoxifen.
  • Toulouse, France
    Institut Universitaire du Cancer de Toulouse - Oncopole
Mar 28, 2022

Breast Cancer, Early Breast Cancer Trial (Camizestrant, Tamoxifen, Anastrozole)

Not yet recruiting
  • Breast Cancer, Early Breast Cancer
  • (no location specified)
Jul 11, 2023

Metastatic Breast Cancer, Hormone Receptor Positive Trial in United States (Palbociclib, Tamoxifen, Fulvestrant)

Completed
  • Metastatic Breast Cancer
  • Hormone Receptor Positive
  • San Francisco, California
  • +8 more
Feb 16, 2022

Breast Cancer, Breast Cancer - Female, Breast Cancer - Male Trial in Tampa (Tamoxifen, Ribociclib, Goserelin)

Completed
  • Breast Cancer
  • +2 more
  • Tamoxifen
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 13, 2022

Ovarian Cancer Trial in Sydney (SUBA-itraconazole, Tamoxifen)

Not yet recruiting
  • Ovarian Cancer
  • Sydney, New South Wales, Australia
    Kinghorn Cancer Centre, St. Vincent's Hospital
Dec 13, 2021

Breast Cancer Trial in Beijing, Guangzhou (TQB3616 capsules, Letrozole, Anastrozole, Tamoxifen, Placebo capsules, Letrozole,

Not yet recruiting
  • Breast Cancer
  • TQB3616 capsules, Letrozole, Anastrozole, Tamoxifen
  • Placebo capsules, Letrozole, Anastrozole, Tamoxifen
  • Beijing, Beijing, China
  • +1 more
Mar 10, 2023

Tamoxifen in Breast Cancer and in Women at High-Risk of Breast

Active, not recruiting
  • Breast Cancer
  • +3 more
  • citalopram hydrobromide
  • +10 more
  • Indianapolis, Indiana
  • +3 more
Feb 18, 2022

Estrogen Receptor Positive Breast Cancer Trial in Houston, Sugar Land (TAK-228, Tamoxifen)

Completed
  • Estrogen Receptor Positive Breast Cancer
  • Houston, Texas
  • +2 more
Aug 27, 2021

Neutrophil Extracellular Traps Formation in Breast Cancer

Recruiting
  • Breast Carcinoma
  • Biospecimen Collection
  • Electronic Health Record Review
  • Houston, Texas
    M D Anderson Cancer Center
Sep 27, 2022

Breast Cancer, HER2-negative Breast Cancer, ER Positive Breast Cancer Trial in Stanford (Infigratinib, Tamoxifen, Omnipaque 350)

Recruiting
  • Breast Cancer
  • +3 more
  • Stanford, California
    Stanford University
Feb 16, 2022

Breast Cancer Trial in Milan (Tamoxifen, Placebo)

Active, not recruiting
  • Breast Cancer
  • Tamoxifen
  • Placebo
  • Milan, Italy
    European Institute of Oncology
Aug 12, 2021

COVID-19 Trial (Drug: Isotretinoin plus Tamoxifen, Aerosolized Isotretinoin plus Tamoxifen)

Not yet recruiting
  • COVID-19
  • Drug: Isotretinoin plus Tamoxifen
  • Aerosolized Isotretinoin plus Tamoxifen
  • (no location specified)
Jul 10, 2021

Breast Cancer Female Trial (All trans-retinoic acid, 13-Cis Retinoic Acid plus Tocopherol, Mifepristone)

Not yet recruiting
  • Breast Cancer Female
  • All trans-retinoic acid
  • +6 more
  • (no location specified)
Aug 17, 2021

Ductal Carcinoma in Situ Trial (Tamoxifen, Exemestane, Letrozole)

Not yet recruiting
  • Ductal Carcinoma in Situ
  • Tamoxifen
  • +5 more
  • (no location specified)
Oct 13, 2023

Breast Cancer Trial in Singapore (Tamoxifen)

Recruiting
  • Breast Cancer
  • Tamoxifen
  • Singapore, Singapore
    National Cancer Centre
Jul 5, 2021

Breast Cancer. Real Clinical Practice in Russia

Recruiting
  • Breast Cancer
  • Neoadjuvant Endocrine Therapy
  • Tamoxifen 20mg
  • +4 more
  • Moscow, Russian Federation
    Blokhin's Russian Cancer Research Center
Apr 5, 2023

ER+ Breast Cancer Trial in Jakarta (Tamoxifen dose adjustment)

Completed
  • ER+ Breast Cancer
  • Tamoxifen dose adjustment
  • Jakarta, DKI Jakarta, Indonesia
    MRCCC Siloam Hospital Semanggi
Aug 4, 2021

Metastatic Breast Cancer Trial in Pittsburgh (Fulvestrant, Tamoxifen, Palbociclib)

Active, not recruiting
  • Metastatic Breast Cancer
  • Pittsburgh, Pennsylvania
    Magee-Womens Hospital UPMC
Jul 22, 2021

HR Positive HER2 Negative Advanced Breast Cancer Trial in Tianjin (Chidamide)

Recruiting
  • HR Positive HER2 Negative Advanced Breast Cancer
  • Tianjin, China
    天津市肿瘤医院
May 26, 2023

Breast Cancer Trial in Jakarta (Tamoxifen)

Active, not recruiting
  • Breast Cancer
  • Tamoxifen
  • Jakarta, DKI Jakarta, Indonesia
    MRCCC Siloam Hospitals Semanggi
Aug 12, 2022

Breast Cancer Trial in Lexington, East Syracuse (TOL2506, Tamoxifen, Letrozole tablets)

Enrolling by invitation
  • Breast Cancer
  • Lexington, Kentucky
  • +1 more
Jan 9, 2023

Breast Cancer Trial (Fluzoparib, Anastrozole, Letrozole)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Jun 5, 2023

Male Breast Cancer, Hormone Receptor-positive Breast Cancer, Hormone Receptor Negative Breast Carcinoma Trial in Boston

Not yet recruiting
  • Male Breast Cancer
  • +2 more
  • Tamoxifen
  • +3 more
  • Boston, Massachusetts
  • +1 more
Aug 12, 2022

Breast Tumors Trial in Worldwide (Palbociclib, Placebo, Tamoxifen)

Active, not recruiting
  • Breast Neoplasms
  • Nagoya, Aichi, Japan
  • +22 more
Apr 4, 2022

Breast Cancer Invasive Trial in Seoul (Leuplin or zoladex)

Recruiting
  • Breast Cancer Invasive
  • Leuplin or zoladex
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Oct 16, 2022